Hybrid hydrogels are recognized as worthwhile substrates, which are extensively used in biopharmaceutical and biomedical applications due to their profound properties such as low mechanical irritation of surrounding cells, controllable biodegradability, and biocompatibility in vitro and in vivo (
1,
2). A functional hydrogel-based scaffold plays a critical role in cell attachment, growth, and tissue fabrication as well as released drug (
1-
3). Various composite hydrogels have been prepared from inert, inactive, and bioactive substrates in multiple fields of biomedical applications due to biocompatibility and biodegradation. Furthermore, inorganic materials with bioactive properties are utilized to direct cells toward specific target cells and tissues (
4,
5). Among these substrates, alginate, a polyelectrolyte with negative charges on its backbone, has been widely used in tissue engineering and regenerative medicine due to its excellent biocompatibility, relatively low cost, and easy gelation in variable ways of crosslinking systems. Alginate-based hydrogel could form three dimensional network through anionic crosslinking reactions with divalent cations such as Ca
2+, as well as chemical crosslinking, including enzymatic or photo-initiation approaches (
4-
6). In addition, chitosan is a linear cationic polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine residues. In general, chitosan is obtained from the thermochemical deacetylation of chitin in the presence of alkali or from certain fungi naturally (
4,
6). It has been widely used in pharmaceutical and biomedical applications, due to its biological properties such as biocompatibility, low toxicity, and good characteristics for cell culture systems (
6-
10). Moreover, chitosan could be crosslinked with negatively charged molecules through electrostatic interactions such as sulfur-containing amino acids, glycosaminoglycans, proteoglycans, and growth factors (
10,
11). These properties allow chitosan to bound and retain bioactive molecules on its structure (
10,
11). Chitosan nanoparticle is produced by exploiting different techniques via ultrasonication or ionic gelation (
6,
12). Ultrasonication arises from acoustic cavitation phenomenon, which generates strong shear forces through the generation of rapid solvent molecule streaming, which leads to cavitation of bubbles and raises shock waves during bubble collapse (
12). The shear forces cut 1, 4-glycosidic bonds of chitosan that is aggregated; consequently, the size of particles is reduced in nano-dimension scale (
12-
14). On the other hand, taurine, a non-protein amino acid containing sulfur, is found in biological fluids and tissues and is the end product of cysteine metabolism in the body (
12-
14). Taurine has been implicated various beneficial physiological functions and biomedical actions, including anti-oxidation, neuromodulation, membrane stabilization, as well as the regulation of calcium homeostasis and metabolism of lipids. Introduction of such a sulfur-containing group to the molecule of chitosan is performed either by sulfoalkylation that results in the N, O-substituted products or direct sulfonation such as regioselective reaction (
11,
13,
14). In this study, we have attempted to encapsulate taurine within nano-structured chitosan followed by ionic interaction of oppositely charged molecules to provide a suitable substrate for cell culture systems and drug delivery applications (
Figure 1).
We first demonstrate the possibility of obtaining taurine-loaded chitosan nanoparticle through the electrostatic interaction of taurine and chitosan and ionic gelation technique. Here, we specifically focused on the tunability of the hydrogelation manner and characteristics of the resultant hydrogel. The taurine was loaded into chitosan nanoparticle composed with alginate gelated through divalent Ca2+cation, then cytocompatibility of this hybrid hydrogel was evaluated for tissue engineering and drug delivery applications.